Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Central Nervous System Metastases|Leptomeningeal Metastases|Recurrent Breast Cancer|Stage IV Breast Cancer|Tumors Metastatic to Brain
Interventions: DRUG: methotrexate|DRUG: liposomal cytarabine|OTHER: quality-of-life assessment|OTHER: laboratory biomarker analysis
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)